| Size | Price | Stock | Qty |
|---|---|---|---|
| 1g |
|
||
| 5g |
|
||
| Other Sizes |
| Targets |
Methyl 12-aminododecanoate hydrochloride does not target a specific protein or enzyme in biological systems. As a PROTAC linker compound, its utility lies in its chemical structure rather than pharmacological target engagement. The terminal amine group provides a reactive handle for conjugation to other molecules, while the long hydrophobic alkyl chain can serve as a spacer in bifunctional molecules such as PROTACs (Proteolysis-Targeting Chimeras). The hydrochloride salt form enhances water solubility, facilitating its use in aqueous biochemical reactions. The compound may interact with biological membranes due to its amphiphilic nature, but this is not a specific receptor-mediated interaction.
|
|---|---|
| ln Vitro |
The in vitro activity of Methyl 12-aminododecanoate hydrochloride is primarily related to its function as a chemical reagent rather than a pharmacologically active compound. As a sulfonylation reagent for organic synthesis and drug discovery, it participates in chemical reactions where the amine group can be modified or used to form amide bonds. The compound can be utilized as a biomaterial for life science related research. Its long alkyl chain makes it suitable for studies involving membrane interactions, lipid modification, or as a building block for more complex molecules. No specific pharmacological in vitro activities such as enzyme inhibition or receptor modulation have been reported for this compound.
|
| ln Vivo |
No significant in vivo activity has been reported for Methyl 12-aminododecanoate hydrochloride, as the compound is primarily utilized as a biochemical reagent and chemical intermediate rather than a pharmacologically active agent. The compound is not intended for therapeutic use in living organisms. Any in vivo effects would be related to its properties as a chemical reagent rather than specific biological activities. The compound's long-chain fatty acid ester structure might interact with lipid metabolism pathways if administered systemically, but such studies have not been reported.
|
| Enzyme Assay |
In vitro enzyme/receptor binding assays are not typically performed for Methyl 12-aminododecanoate hydrochloride, as it functions as a chemical reagent rather than a drug candidate targeting specific enzymes or receptors. The compound is used in organic synthesis and drug discovery as a building block. If binding studies were to be conducted, they would likely involve assessing the compound's interaction with biological membranes or its incorporation into lipid structures rather than specific receptor binding. Standard assay protocols would involve dissolving the compound in appropriate solvents and incubating with target molecules or membranes.
|
| Cell Assay |
For in vitro cellular experiments, Methyl 12-aminododecanoate hydrochloride is dissolved in DMSO or other suitable solvents and diluted in cell culture medium. The compound may be used to study the effects of fatty acid derivatives on cellular processes or as a precursor for synthesizing bioactive molecules. As a PROTAC linker, it can be incorporated into larger molecules that are then tested in cellular assays. Standard cell viability, proliferation, or uptake studies could be performed, but specific protocols are not well-documented in the literature for this compound.
|
| Animal Protocol |
In vivo animal experiments with Methyl 12-aminododecanoate hydrochloride are not commonly performed, as the compound is primarily a research reagent rather than a therapeutic candidate. The compound is not intended for administration to living organisms. If used in animal studies, it would most likely be as a synthetic intermediate for preparing other compounds that are subsequently tested in vivo, rather than being administered directly.
|
| ADME/Pharmacokinetics |
Pharmacokinetic properties of Methyl 12-aminododecanoate hydrochloride have not been characterized, as the compound is a research-use chemical reagent rather than a drug candidate. The compound has a molecular weight of 265.82 g/mol and is soluble in organic solvents. As a fatty acid ester derivative, if absorbed, it would likely be metabolized by esterases and undergo fatty acid oxidation pathways. However, no specific PK data including half-life, clearance, volume of distribution, or bioavailability has been reported for this compound.
|
| Toxicity/Toxicokinetics |
The compound has a molecular weight of 265.82 and a molecular formula of C₁₃H₂₈ClNO₂. Toxicological data for Methyl 12-aminododecanoate hydrochloride has not been systematically evaluated, as the compound is intended for research applications only and not for therapeutic use. Standard laboratory safety precautions should be observed when handling this chemical reagent, including the use of appropriate personal protective equipment and working in a well-ventilated area. The compound should be stored away from direct sunlight.
|
| Additional Infomation |
Methyl 12-aminododecanoate hydrochloride (CAS# 4271-86-7) is a biochemical compound that can be utilized as a biomaterial or organic/chemical reagent for biomedical research. It is classified as a PROTAC linker compound, indicating its utility in the synthesis of proteolysis-targeting chimeras for targeted protein degradation. The compound can also serve as a sulfonylation reagent for organic synthesis and drug discovery. It is intended for laboratory use only and has no clinical or therapeutic applications.
|
| Molecular Formula |
C13H28CLNO2
|
|---|---|
| Molecular Weight |
265.82
|
| Exact Mass |
265.181
|
| CAS # |
4271-86-7
|
| PubChem CID |
19372000
|
| Appearance |
White to off-white solid powder
|
| LogP |
4.521
|
| Hydrogen Bond Donor Count |
2
|
| Hydrogen Bond Acceptor Count |
3
|
| Rotatable Bond Count |
12
|
| Heavy Atom Count |
17
|
| Complexity |
160
|
| Defined Atom Stereocenter Count |
0
|
| SMILES |
COC(=O)CCCCCCCCCCCN.Cl
|
| InChi Key |
UZAPWACCYWKXEL-UHFFFAOYSA-N
|
| InChi Code |
InChI=1S/C13H27NO2.ClH/c1-16-13(15)11-9-7-5-3-2-4-6-8-10-12-14;/h2-12,14H2,1H3;1H
|
| Chemical Name |
methyl 12-aminododecanoate;hydrochloride
|
| HS Tariff Code |
2934.99.9001
|
| Storage |
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month Note: This product requires protection from light (avoid light exposure) during transportation and storage. |
| Shipping Condition |
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
|
| Solubility (In Vitro) |
May dissolve in DMSO (in most cases), if not, try other solvents such as H2O, Ethanol, or DMF with a minute amount of products to avoid loss of samples
|
|---|---|
| Solubility (In Vivo) |
Note: Listed below are some common formulations that may be used to formulate products with low water solubility (e.g. < 1 mg/mL), you may test these formulations using a minute amount of products to avoid loss of samples.
Injection Formulations
Injection Formulation 1: DMSO : Tween 80： Saline = 10 : 5 : 85 (i.e. 100 μL DMSO stock solution → 50 μL Tween 80 → 850 μL Saline)(e.g. IP/IV/IM/SC) *Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH ₂ O to obtain a clear solution. Injection Formulation 2: DMSO : PEG300 ：Tween 80 : Saline = 10 : 40 : 5 : 45 (i.e. 100 μL DMSO → 400 μLPEG300 → 50 μL Tween 80 → 450 μL Saline) Injection Formulation 3: DMSO : Corn oil = 10 : 90 (i.e. 100 μL DMSO → 900 μL Corn oil) Example: Take the Injection Formulation 3 (DMSO : Corn oil = 10 : 90) as an example, if 1 mL of 2.5 mg/mL working solution is to be prepared, you can take 100 μL 25 mg/mL DMSO stock solution and add to 900 μL corn oil, mix well to obtain a clear or suspension solution (2.5 mg/mL, ready for use in animals). View More
Injection Formulation 4: DMSO : 20% SBE-β-CD in saline = 10 : 90 [i.e. 100 μL DMSO → 900 μL (20% SBE-β-CD in saline)] Oral Formulations
Oral Formulation 1: Suspend in 0.5% CMC Na (carboxymethylcellulose sodium) Oral Formulation 2: Suspend in 0.5% Carboxymethyl cellulose Example: Take the Oral Formulation 1 (Suspend in 0.5% CMC Na) as an example, if 100 mL of 2.5 mg/mL working solution is to be prepared, you can first prepare 0.5% CMC Na solution by measuring 0.5 g CMC Na and dissolve it in 100 mL ddH2O to obtain a clear solution; then add 250 mg of the product to 100 mL 0.5% CMC Na solution, to make the suspension solution (2.5 mg/mL, ready for use in animals). View More
Oral Formulation 3: Dissolved in PEG400 (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 3.7619 mL | 18.8097 mL | 37.6194 mL | |
| 5 mM | 0.7524 mL | 3.7619 mL | 7.5239 mL | |
| 10 mM | 0.3762 mL | 1.8810 mL | 3.7619 mL |
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.
Calculation results
Working concentration： mg/mL；
Method for preparing DMSO stock solution： mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.
Method for preparing in vivo formulation:：Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O，mix and clarify.
(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
(2) Be sure to add the solvent(s) in order.
Products are for research use only; We do not sell to patients
Copyright 2020 InvivoChem LLC | All Rights Reserved
